1. Exenatide improves antioxidant capacity and reduces the expression of LDL receptors and PCSK9 in human insulin-secreting 1.1E7 cell line subjected to hyperglycemia and oxidative stress
    Łukasz Bułdak et al, 2022, Postępy Higieny i Medycyny Doświadczalnej CrossRef
  2. GLP-1 receptor agonists in the treatment of diabetic non–alcoholic steatohepatitis patients
    Ernest A. Adeghate, 2024, Expert Opinion on Pharmacotherapy CrossRef
  3. Diabetic Theory in Anti-Alzheimer’s Drug Research and Development. Part 2: Therapeutic Potential of cAMP-Specific Phosphodiesterase Inhibitors
    Agnieszka Jankowska et al, 2021, Current Medicinal Chemistry CrossRef